Navigation Links
Lee Biosolutions Manufactures Enzymes For Determining Alcoholic Liver Disease

Saint Louis, MO (PRWEB) December 31, 2012

Lee Biosolutions Inc, a U.S. manufacture of high purity finished proteins has increased production capacity for important enzymes used in liver function blood tests worldwide. The St. Louis-based healthcare- biotechnology firm has been able to keep up with demand for aminotransferase enzymes by increasing yields through newly developed purification methodologies.

The liver is not only the largest organ but the largest gland in the human body which plays an important role by filtering and processing blood as it circulates through the body. The functions of the liver include detoxification of your blood, production of important clotting factors and other proteins, processing nutrients, waste products of hemoglobin and storing vitamins, cholesterol and bile while also producing glucose. The cells in the liver contain proteins called enzymes that drive these chemical reactions. When the liver cells are damaged or destroyed, the enzymes in the cells leak out to the blood where they can be measured by blood tests. The liver function tests include measuring two main enzymes, Aspartate Aminotransferase called AST (GOT) and Alanine Aminotransferase ALT (SGPT) which when elevated is a strong sign of liver damage or disease.

According to Burton Lee, President of Lee Biosolutions, “The enzymes that are produced for liver function tests are actually isolated from porcine and bovine sources at our facility in St. Louis. Our production chemists process literally thousands of kgs of high quality tissue from USDA slaughter houses at a time in order to isolate and purify just a few hundred grams of a single enzyme. Careful monitoring of critical points in the process is needed to insure a stable high quality product. Our finished enzymes are then purchased under strict specifications by major IVD companies such as Bio-Rad Laboratories who produce the reagents and blood tests for hospitals to aid in the diagnoses if someone has alcoholic liver disease, viral hepatitis, and acute or chronic liver injury. Its very satisfying to know the products that you produce are helping save lives."

About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer high purity finished proteins. Headquartered in St. Louis and founded in 2002, the healthcare biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes proteins and antibodies used in drug discovery and development, clinical diagnostic and immunodiagnostic market. The company is ISO 9001:2008 certified, has an active fan base on facebook certified, and is FDA and APHIS certified. To learn more about Lee BioSolutions visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
2. Global Markets for Enzymes in Industrial Applications
3. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
4. Gevo Doesnt Infringe Butamaxs 017 Patent; Gevo was First to Invent Enzyme in 017 Patent; Gevo has Advanced Beyond That and Now Uses Different Enzymes
5. Science study shows promiscuous enzymes still prevalent in metabolism
6. Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
7. NIH Awards New England Biolabs a Phase II SBIR Grant for the Research and Development of Novel Enzymes for Epigenetic Studies
8. Marshall study shows nanoparticles used as additives in diesel fuels can travel from lungs to liver
9. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
10. Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery
11. ResearchMoz: Nanotech Enabled Drug Delivery Therapeutics Market Will be $136 Billion by the Year 2021: Nanotechnology in Drug Delivery: Global Markets
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... SHPG ) announced today that Jeff Poulton , ... Annual Healthcare Conference in New York City ... (1:30 p.m. GMT). --> SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> Shire ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that the remaining 11,000 post-share consolidation (or 1,100,000 ... (the "Series B Warrants") subject to the previously ... November 23, 2015, which will result in the ... effect to the issuance of such shares, there ...
Breaking Biology Technology:
(Date:11/18/2015)... 18, 2015 --> ... new market report titled  Gesture Recognition Market - Global ... - 2021. According to the report, the global gesture recognition market was ... to reach US$29.1 bn by 2021, at a CAGR ... North America dominated the global gesture recognition ...
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
Breaking Biology News(10 mins):